Filing Details
- Accession Number:
- 0001179110-17-014859
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-04 18:21:27
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-04 18:21:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1578845 | Allergan Plc | AGN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1536778 | William Meury | Clonshaugh Business And Technology Park, Coolock, Co. Dublin L2 D17 E400 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2017-12-01 | 9,272 | $78.88 | 66,293 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2017-12-01 | 2,535 | $78.88 | 68,828 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value $0.0001 | Disposition | 2017-12-01 | 9,272 | $173.89 | 59,556 | No | 4 | S | Direct | |
| Ordinary Shares, Par Value $0.0001 | Disposition | 2017-12-01 | 2,535 | $173.89 | 57,021 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non-Qualified Options to Purchase Common Stock | Disposition | 2017-12-01 | 9,272 | $0.00 | 9,272 | $78.88 |
| Ordinary Shares | Incentive Stock Option | Disposition | 2017-12-01 | 2,535 | $0.00 | 2,535 | $78.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-12-05 | No | 4 | M | Direct | |
| 0 | 2017-12-05 | No | 4 | M | Direct |
Footnotes
- The option vested in five equal installments on December 6, 2008, 2009, 2010, 2011 and 2012.
- The option vested in two equal installments on December 6, 2011 and 2012.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.51to $174.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
Billionaire Hedge Funds
